Qingliang Zhao

Dr. Qingliang Zhao

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
LYLinhai Yang
Linhai Yang
YCYulun Chen
Yulun Chen
SLShuting Ling
Shuting Ling
JWJing Wang
Jing Wang
GWGuangxing Wang
Guangxing Wang
MJMao Jingsong
Mao Jingsong
Optical coherence tomography (OCT) is a non-invasive imaging technique which has become the “gold standard” for diagnosis in the field of ophthalmology. However, in contrast to the eye, nontransparent tissues exhibit a high degree of optical scattering and absorption, resulting in a limited OCT imaging depth. And the progress made in the past decade in OCT technology have made it possible to image nontransparent tissues with high spatial resolution at large (up to 2mm) imaging depth. On the one hand, OCT can be used in a rapid, noninvasive way to detect diseased tissues, organs, blood vessels or glands. On the other hand, it can also identify the optical characteristics of suspicious parts in the early stage of the disease, which is of great significance for the early diagnosis of tumor diseases. Furthermore, OCT imaging has been explored for imaging tumor cells and their dynamics, and for the monitoring of tumor responses to treatments. This review summarizes the recent advances in the OCT area, which application in oncological diagnosis and treatment in different types: (1) superficial tumors:OCT could detect microscopic information on the skin’s surface at high resolution and has been demonstrated to help diagnose common skin cancers; (2) gastrointestinal tumors: OCT can be integrated into small probes and catheters to image the structure of the stomach wall, enabling the diagnosis and differentiation of gastrointestinal tumors and inflammation; (3) deep tumors: with the rapid development of OCT imaging technology, it has shown great potential in the diagnosis of deep tumors such in brain tumors, breast cancer, bladder cancer, and lung cancer.

23 July 2020 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
ZMZhaohua Miao
Zhaohua Miao
DHDoudou Huang
Doudou Huang
YWYichuan Wang
Yichuan Wang
WLWei‐Jian Li
Wei‐Jian Li
LFLinxin Fan
Linxin Fan
ZZZhengbao Zha
Zhengbao Zha

8 August 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
YQYuwei Qiu
Yuwei Qiu
DDDandan Ding
Dandan Ding
WSWenjing Sun
Wenjing Sun
YFYushuo Feng
Yushuo Feng
DHDoudou Huang
Doudou Huang
HCHongmin Chen
Hongmin Chen
Carbon-based light-activated materials can absorb optical energy to generate photoacoustic (PA) signals for imaging or transduce optical photons to thermal energy, which holds great promise for biomedical applications. Herein, we synthesize hollow and mesoporous carbon nanospheres (HMCNs) with uniform size on a large scale. The properties of hollow cavity and mesoporous structures make the HMCNs achieve high drug loading (480 mg DOX per g HMCNs). The present intense near infrared (NIR) absorbance achieves excellent photoacoustic imaging ability and photothermal conversion efficacy (32.0%). More interestingly, the encapsulated drugs can have a triggered release under NIR irradiation. The investigations in vitro and in vivo demonstrate that HMCNs have excellent biocompatibility, and accumulate in tumors by the enhanced permeability and retention (EPR) effect. Moreover, under NIR irradiation, in vivo evaluation shows that HMCNs can perform strong PA imaging, and induce great tumor inhibition by the combination of chemotherapy and PTT under the guidance of photoacoustic imaging. The present study provides new insight for design of novel biocompatible light-activated carbons for cancer nanotheranostics.

19 June 2023 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
SFSuzhong Fu
Suzhong Fu
JXJing Xu
Jing Xu
SCShilong Chang
Shilong Chang
LYLuyao Yang
Luyao Yang
SLShuting Ling
Shuting Ling
Qingliang ZhaoQingliang Zhao
Qingliang Zhao
Laser speckle contrast imaging (LSCI) is widely used for in vivo real-time detection and analysis of local blood flow microcirculation due to its non-invasive ability and excellent spatial and temporal resolution. However, vascular segmentation of LSCI images still faces a lot of difficulties due to numerous specific noises caused by the complexity of blood microcirculation’s structure and irregular vascular aberrations in diseased regions. In addition, the difficulties of LSCI image data annotation have hindered the application of deep learning methods based on supervised learning in the field of LSCI image vascular segmentation. To tackle these difficulties, we propose a robust weakly supervised learning method, which selects the threshold combinations and processing flows instead of labor-intensive annotation work to construct the ground truth of the dataset, and design a deep neural network, FURNet, based on UNet++ and ResNeXt. The model obtained from training achieves high-quality vascular segmentation and captures multi-scene vascular features on both constructed and unknown datasets with good generalization. Furthermore, we intravital verified the availability of this method on a tumor before and after embolization treatment. This work provides a new approach for realizing LSCI vascular segmentation and also makes a new application-level advance in the field of artificial intelligence-assisted disease diagnosis.

15 July 2019 in Small
Verified
Journal Article
Closed access
PDF file
YHYali Huang
Yali Huang
MLMinghui Li
Minghui Li
DHDoudou Huang
Doudou Huang
QQQi Qiu
Qi Qiu
WLWenzhen Lin
Wenzhen Lin
XCXiaoyuan Chen
Xiaoyuan Chen

10 June 2021 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
YYYifan Yang
Yifan Yang
ZFZhongxiong Fan
Zhongxiong Fan
KZKaili Zheng
Kaili Zheng
DSDao Shi
Dao Shi
GSGuanghao Su
Guanghao Su
ZFZhongxiong Fan
Zhongxiong Fan
Sonodynamic therapy has attracted wide attention as a noninvasive therapy due to deep tissue penetration. However, majority sonosensitizers often suffer from poor physiological stability, rapid blood clearance and nonspecific targeting, which seriously hinders their further practical applications. Inspired by the concept of active targeting drug delivery, both dual-functional chemo-drug pemetrexed (PEM, emerges an innate affinity toward the folate receptor) and amphiphilic D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) were selected to be covalently linked by an esterase-responsive ester linkage. The synthesized self-targeting TPGS–PEM prodrug and indocyanine green (ICG) as functional motifs can be self-assembled into a TPGS–PEM–ICG nanoplatform within an aqueous medium. The TPGS–PEM–ICG nanoplatform with outstanding structural and physiological stability not only protects the sonosensitizer from reticular endothelial system clearance but also achieves active targeting drug delivery and efficient tumor enrichment. Moreover, TPGS–PEM–ICG nanoplatform can selectively recognize tumor cells and then realize on-demand drug burst release by multiple stimuli of internal lysosomal acidity, esterase and external ultrasound, which guarantee low side effects toward normal tissues and organs. It is also worth noting that our nanoplatform exhibits protruding tumor enrichment under the precise guidance of photoacoustic/fluorescence imaging. Further in vitro and in vivo experimental results well confirmed that the TPGS–PEM–ICG nanoplatform possesses enhanced chemo-sonodynamic effects. Interestingly, the highly toxic reactive oxygen species can remarkably reduce the blood oxygen saturation signal of the tumor microenvironment via precise, multifunctional and high-resolution photoacoustic imaging. Taken together, the TPGS–PEM–ICG nanoplatform can be expected to hold enormous potential for diagnosis, prognosis and targeted therapy for tumor.